Resistance to Cotrimoxazole and Other Antimicrobials among Isolates from HIV/AIDS and Non-HIV/AIDS Patients at Bugando Medical Centre, Mwanza, Tanzania

Bacterial resistance has increased in the AIDS era and is attributed to the widespread use of cotrimoxazole prophylaxis against opportunistic infections in HIV/AIDS patients. In Tanzania, cotrimoxazole prophylaxis has been used for more than ten years. Little is known, however, about its impact on t...

Full description

Saved in:
Bibliographic Details
Main Authors: Karol J. Marwa, Martha F. Mushi, Eveline Konje, Paul E. Alele, Jeremiah Kidola, Mariam M. Mirambo
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:AIDS Research and Treatment
Online Access:http://dx.doi.org/10.1155/2015/103874
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849408853133754368
author Karol J. Marwa
Martha F. Mushi
Eveline Konje
Paul E. Alele
Jeremiah Kidola
Mariam M. Mirambo
author_facet Karol J. Marwa
Martha F. Mushi
Eveline Konje
Paul E. Alele
Jeremiah Kidola
Mariam M. Mirambo
author_sort Karol J. Marwa
collection DOAJ
description Bacterial resistance has increased in the AIDS era and is attributed to the widespread use of cotrimoxazole prophylaxis against opportunistic infections in HIV/AIDS patients. In Tanzania, cotrimoxazole prophylaxis has been used for more than ten years. Little is known, however, about its impact on the spread of antibiotic resistance in HIV positive patients. This cross-sectional study was done to compare magnitude of bacterial resistance to cotrimoxazole and other antimicrobials among isolates from HIV infected patients on cotrimoxazole prophylaxis and those not on prophylaxis and non-HIV patients attending Bugando Medical Centre (BMC). Susceptibility testing on obtained urine and swab specimens followed Clinical Laboratory Standard Institute, 2010, Guidelines. Of 945 samples collected, 155 had positive bacterial growth after 24 hours of incubation. Of the positive samples (72), 46.4% were from HIV positive patients. The common isolates were E. coli 41.3% (64/155), Klebsiella pneumoniae 17.5% (27/155), and Staphylococcus aureus 16.1% (25/155). Overall, bacterial resistance to cotrimoxazole was 118 (76.1%); among isolates from HIV patients bacterial resistance was 54 (75%), and for isolates from HIV patients on prophylaxis bacterial resistance was 36 (81.3%). HIV seropositivity and cotrimoxazole prophylaxis are not associated with antibiotic resistance observed in bacteria infecting patients attending BMC, Mwanza, Tanzania.
format Article
id doaj-art-7f2d13cbfe504c8dbc7168aeb8a65ad6
institution Kabale University
issn 2090-1240
2090-1259
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series AIDS Research and Treatment
spelling doaj-art-7f2d13cbfe504c8dbc7168aeb8a65ad62025-08-20T03:35:40ZengWileyAIDS Research and Treatment2090-12402090-12592015-01-01201510.1155/2015/103874103874Resistance to Cotrimoxazole and Other Antimicrobials among Isolates from HIV/AIDS and Non-HIV/AIDS Patients at Bugando Medical Centre, Mwanza, TanzaniaKarol J. Marwa0Martha F. Mushi1Eveline Konje2Paul E. Alele3Jeremiah Kidola4Mariam M. Mirambo5Department of Clinical Pharmacology, Weill Bugando School of Medicine, P.O. Box 1464, Mwanza, TanzaniaMicrobiology and Immunology Department, Weill Bugando School of Medicine, P.O. Box 1464, Mwanza, TanzaniaDepartment of Community Medicine, School of Public Health, Catholic University of Health and Allied Sciences, P.O. Box 1464, Mwanza, TanzaniaDepartment of Pharmacology, Mbarara University of Science and Technology, P.O. Box 1410, Mbarara, UgandaNational Institute for Medical Research, P.O. Box 1462, Mwanza, TanzaniaMicrobiology and Immunology Department, Weill Bugando School of Medicine, P.O. Box 1464, Mwanza, TanzaniaBacterial resistance has increased in the AIDS era and is attributed to the widespread use of cotrimoxazole prophylaxis against opportunistic infections in HIV/AIDS patients. In Tanzania, cotrimoxazole prophylaxis has been used for more than ten years. Little is known, however, about its impact on the spread of antibiotic resistance in HIV positive patients. This cross-sectional study was done to compare magnitude of bacterial resistance to cotrimoxazole and other antimicrobials among isolates from HIV infected patients on cotrimoxazole prophylaxis and those not on prophylaxis and non-HIV patients attending Bugando Medical Centre (BMC). Susceptibility testing on obtained urine and swab specimens followed Clinical Laboratory Standard Institute, 2010, Guidelines. Of 945 samples collected, 155 had positive bacterial growth after 24 hours of incubation. Of the positive samples (72), 46.4% were from HIV positive patients. The common isolates were E. coli 41.3% (64/155), Klebsiella pneumoniae 17.5% (27/155), and Staphylococcus aureus 16.1% (25/155). Overall, bacterial resistance to cotrimoxazole was 118 (76.1%); among isolates from HIV patients bacterial resistance was 54 (75%), and for isolates from HIV patients on prophylaxis bacterial resistance was 36 (81.3%). HIV seropositivity and cotrimoxazole prophylaxis are not associated with antibiotic resistance observed in bacteria infecting patients attending BMC, Mwanza, Tanzania.http://dx.doi.org/10.1155/2015/103874
spellingShingle Karol J. Marwa
Martha F. Mushi
Eveline Konje
Paul E. Alele
Jeremiah Kidola
Mariam M. Mirambo
Resistance to Cotrimoxazole and Other Antimicrobials among Isolates from HIV/AIDS and Non-HIV/AIDS Patients at Bugando Medical Centre, Mwanza, Tanzania
AIDS Research and Treatment
title Resistance to Cotrimoxazole and Other Antimicrobials among Isolates from HIV/AIDS and Non-HIV/AIDS Patients at Bugando Medical Centre, Mwanza, Tanzania
title_full Resistance to Cotrimoxazole and Other Antimicrobials among Isolates from HIV/AIDS and Non-HIV/AIDS Patients at Bugando Medical Centre, Mwanza, Tanzania
title_fullStr Resistance to Cotrimoxazole and Other Antimicrobials among Isolates from HIV/AIDS and Non-HIV/AIDS Patients at Bugando Medical Centre, Mwanza, Tanzania
title_full_unstemmed Resistance to Cotrimoxazole and Other Antimicrobials among Isolates from HIV/AIDS and Non-HIV/AIDS Patients at Bugando Medical Centre, Mwanza, Tanzania
title_short Resistance to Cotrimoxazole and Other Antimicrobials among Isolates from HIV/AIDS and Non-HIV/AIDS Patients at Bugando Medical Centre, Mwanza, Tanzania
title_sort resistance to cotrimoxazole and other antimicrobials among isolates from hiv aids and non hiv aids patients at bugando medical centre mwanza tanzania
url http://dx.doi.org/10.1155/2015/103874
work_keys_str_mv AT karoljmarwa resistancetocotrimoxazoleandotherantimicrobialsamongisolatesfromhivaidsandnonhivaidspatientsatbugandomedicalcentremwanzatanzania
AT marthafmushi resistancetocotrimoxazoleandotherantimicrobialsamongisolatesfromhivaidsandnonhivaidspatientsatbugandomedicalcentremwanzatanzania
AT evelinekonje resistancetocotrimoxazoleandotherantimicrobialsamongisolatesfromhivaidsandnonhivaidspatientsatbugandomedicalcentremwanzatanzania
AT paulealele resistancetocotrimoxazoleandotherantimicrobialsamongisolatesfromhivaidsandnonhivaidspatientsatbugandomedicalcentremwanzatanzania
AT jeremiahkidola resistancetocotrimoxazoleandotherantimicrobialsamongisolatesfromhivaidsandnonhivaidspatientsatbugandomedicalcentremwanzatanzania
AT mariammmirambo resistancetocotrimoxazoleandotherantimicrobialsamongisolatesfromhivaidsandnonhivaidspatientsatbugandomedicalcentremwanzatanzania